$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Antisense oligonucleotide modulation of multidrug resistance-associated protein 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C12N-015/85
  • A61K-048/00
  • C12Q-001/68
  • C07H-021/04
출원번호 US-0835770 (1997-04-08)
발명자 / 주소
  • Baracchini Edgardo
  • Bennett C. Frank
  • Dean Nicholas M.
출원인 / 주소
  • Isis Pharmaceuticals, Inc.
대리인 / 주소
    Law Offices of Jane Massey Licata
인용정보 피인용 횟수 : 615  인용 특허 : 4

초록

Compositions and methods are provided for the treatment and diagnosis of diseases or conditions amenable to treatment through modulation of the synthesis or metabolism of multidrug resistance-associated protein (MRP). In accordance with referred embodiments, oligonucleotides are provided which are s

대표청구항

[ What is claimed is:] [1.] An oligonucleotide comprising 8 to 30 nucleotides specifically hybridizable with a nucleic acid encoding multidrug resistance-associated protein and capable of inhibiting the expression of multidrug resistance-associated protein.

이 특허에 인용된 특허 (4)

  1. Cook P. Dan (Carlsbad CA) Ramasamy Kanda S. (Laguna Hills CA) Manoharan Muthiah (Carlsbad CA), N-2 substituted purines.
  2. Cook Philip D. (Carlsbad CA) Guinosso Charles J. (Carlsbad CA), Polyamine conjugated oligonucleotides.
  3. Cook Philip D. (Carlsbad CA) Guinosso Charles J. (Carlsbad CA), Polyamine conjugated oligonucleotides.
  4. Summerton, James E.; Weller, Dwight D., Uncharged morpholino-based polymers having achiral intersubunit linkages.

이 특허를 인용한 특허 (615)

  1. Hermeking, Heiko; Vogelstein, Bert; Kinzler, Kenneth W., 14-3-3&sgr; arrests the cell cycle.
  2. Prakash, Thazha P.; Baker, Brenda F.; Eldrup, Anne B.; Manoharan, Muthiah; Bhat, Balkrishen; Griffey, Richard; Swayze, Eric E.; Crooke, Stanley T., 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations.
  3. Rohloff, John; Janjic, Nebojsa; Carter, Jeffrey D.; Fowler, Catherine, 5-position modified pyrimidines and their use.
  4. Rohloff, John; Janjic, Nebojsa; Carter, Jeffrey D.; Fowler, Catherine, 5-position modified pyrimidines and their use.
  5. Geary, Richard S.; Yu, Zhengrong; Wedel, Mark K.; Tribble, Diane, Administering antisense oligonucleotides complementary to human apolipoprotein B.
  6. Hope, Michael J.; Semple, Sean C.; Chen, Jianxin; Madden, Thomas D.; Cullis, Pieter R.; Ciufolini, Marco A.; Mui, Barbara Low Shoud, Amino lipids and methods for the delivery of nucleic acids.
  7. Weller, Dwight D.; Geller, Bruce L.; Iversen, Patrick L.; Tilley, Lucas D.; Hassinger, Jed N., Antibacterial antisense oligonucleotide and method.
  8. Larsen, Flemming; Wahlers, Ulla, Antibodies to MASP-2.
  9. Larsen, Flemming; Wahlers, Ulla, Antibodies to MASP-2.
  10. LaCasse, Eric; McManus, Daniel; Durkin, Jon P., Antisense IAP nucleobase oligomers and uses thereof.
  11. LaCasse, Eric; McManus, Daniel; Durkin, Jonathan P., Antisense IAP nucleobase oligomers and uses thereof.
  12. Stein, David A.; Skilling, Douglas E.; Iversen, Patrick L.; Smith, Alvin W.; Weller, Dwight D., Antisense antiviral agent and method for treating ssRNA viral infection.
  13. Iversen, Patrick L., Antisense antiviral compound and method for treating influenza viral infection.
  14. Iversen, Patrick L., Antisense antiviral compound and method for treating influenza viral infection.
  15. Stein, David A.; Ge, Qing; Chen, Jianzhu; Iversen, Patrick L.; Moulton, Hong M., Antisense antiviral compound and method for treating influenza viral infection.
  16. Stein, David A.; Rijnbrand, Cornelis A.; Iversen, Patrick L.; Weller, Dwight D., Antisense antiviral compound and method for treating picornavirus infection.
  17. Iversen, Patrick L.; Stein, David A., Antisense antiviral compound and method for treating ssRNA viral infection.
  18. Iversen, Patrick L.; Stein, David A.; Weller, Dwight D., Antisense antiviral compound and method for treating ssRNA viral infection.
  19. Iversen, Patrick L.; Weller, Dwight D., Antisense antiviral compounds and methods for treating a filovirus infection.
  20. Iversen, Patrick L.; Weller, Dwight D., Antisense antiviral compounds and methods for treating a filovirus infection.
  21. Iversen, Patrick L.; Weller, Dwight D., Antisense antiviral compounds and methods for treating a filovirus infection.
  22. Iversen, Patrick L.; Weller, Dwight D., Antisense antiviral compounds and methods for treating a filovirus infection.
  23. Iversen, Patrick L.; Weller, Dwight D., Antisense antiviral compounds and methods for treating a filovirus infection.
  24. Stein, David A.; Iversen, Patrick L.; Bavari, Sina, Antisense antiviral compounds and methods for treating a filovirus infection.
  25. Stein, David A.; Iversen, Patrick L.; Bavari, Sina; Weller, Dwight D., Antisense antiviral compounds and methods for treating a filovirus infection.
  26. Stein, David A.; Iversen, Patrick L.; Bavari, Sina; Weller, Dwight D., Antisense antiviral compounds and methods for treating a filovirus infection.
  27. Stein, David A.; Iversen, Patrick L.; Bavari, Sina; Weller, Dwight D., Antisense antiviral compounds and methods for treating a filovirus infection.
  28. Stein,David A.; Iversen,Patrick L.; Bavari,Sina; Weller,Dwight D., Antisense antiviral compounds and methods for treating a filovirus infection.
  29. Mourich, Dan V.; Marshall, Nikki B.; Iversen, Patrick L., Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis.
  30. Mourich, Dan V.; Moulton, Hong M.; Hinrichs, David J.; Iversen, Patrick L., Antisense compound for inducing immunological tolerance.
  31. Swayze, Eric E., Antisense compounds.
  32. Freier, Susan M.; Rigo, Frank, Antisense compounds targeting genes associated with fibronectin.
  33. Freier, Susan M.; Rigo, Frank; Dockrell, Mark; Heidibrecht, Felicia, Antisense compounds targeting genes associated with fibronectin.
  34. Christensen, Signe M.; Mikkelsen, Nikolaj Dam; Frieden, Miriam; Hansen, Henrik Frydenlund; Koch, Troels; Pedersen, Daniel Sejer; Rosenbohm, Christoph; Thrue, Charlotte Albaek; Westergaard, Majken, Antisense design.
  35. Christensen, Signe M.; Mikkelsen, Nikolaj Dam; Frieden, Miriam; Hansen, Henrik Frydenlund; Koch, Troels; Pedersen, Daniel Sejer; Rosenbohm, Christoph; Thrue, Charlotte Albaek; Westergaard, Majken, Antisense design.
  36. Christensen, Signe M.; Mikkelsen, Nikolaj Dam; Frieden, Miriam; Hansen, Henrik Frydenlund; Koch, Troels; Pedersen, Daniel Sejer; Rosenbohm, Christoph; Thrue, Charlotte Albaek; Westergaard, Majken, Antisense design.
  37. Christensen, Signe M.; Mikkelsen, Nikolaj Dam; Frieden, Miriam; Hansen, Henrik Frydenlund; Koch, Troels; Pedersen, Daniel Sejer; Rosenbohm, Christoph; Thrue, Charlotte Albaek; Westergaard, Majken, Antisense design.
  38. Christensen, Signe M.; Mikkelsen, Nikolaj Dam; Frieden, Miriam; Hansen, Henrik Frydenlund; Koch, Troels; Pedersen, Daniel Sejer; Thrue, Charlotte Albaek; Westergaard, Majken; Rosenbohm, Christoph, Antisense design.
  39. Brent W. Weston ; Kara M. Hiller, Antisense human fucosyltransferase sequences and methods of use thereof.
  40. C. Frank Bennett ; Jacqueline Wyatt, Antisense inhibition of A20 expression.
  41. Monia Brett P. ; Butler Madeline M. ; Wyatt Jacqueline, Antisense inhibition of C/EBP alpha expression.
  42. Monia Brett P. ; Butler Madeline M. ; Wyatt Jacqueline, Antisense inhibition of C/EBP beta expression.
  43. Monia Brett P. ; Cowsert Lex M., Antisense inhibition of EGR-1 expression.
  44. Baker Brenda F. ; Cowsert Lex M., Antisense inhibition of ETs-2 expression.
  45. Cowsert Lex M., Antisense inhibition of G-alpha-S1 expression.
  46. Nicholas M. Dean ; Lex M. Cowsert, Antisense inhibition of HPK/GCK-like kinase expression.
  47. Bennett, C. Frank; Cowsert, Lex M., Antisense inhibition of Her-2 expression.
  48. Monia Brett P. ; Cowsert Lex M., Antisense inhibition of Jun N-terminal Kinase Kinase-2 expression.
  49. Monia Brett P. ; Cowsert Lex M., Antisense inhibition of MAP kinase kinase 6 expression.
  50. Monia Brett P. ; Cowsert Lex M., Antisense inhibition of PI3K p85 expression.
  51. Brett P. Monia ; Jacqueline Wyatt, Antisense inhibition of Phosphorylase kinase beta expression.
  52. Zeng, Hong; Reddy, Gurucharan; Vallerga, Anne; Zarling, David A., Antisense inhibition of RAD51.
  53. Freier, Susan M., Antisense inhibition of SAP-1 expression.
  54. Bennett C. Frank ; Cowsert Lex M., Antisense inhibition of SHP-2 expression.
  55. Monia Brett P. ; Cowsert Lex M., Antisense inhibition of SMAD2 expression.
  56. Monia Brett P. ; Cowsert Lex M., Antisense inhibition of Smad5 expression.
  57. Taylor Jennifer K. ; Cowsert Lex M., Antisense inhibition of bcl-6 expression.
  58. Brett P. Monia ; Susan M. Freier, Antisense inhibition of clusterin expression.
  59. C. Frank Bennett ; Lex M. Cowsert, Antisense inhibition of cytohesin-1 expression.
  60. Cowsert, Lex M., Antisense inhibition of dual specific phosphatase 9 expression.
  61. Popoff Ian ; Brown-Driver Vickie L. ; Cowsert Lex M., Antisense inhibition of e2f transcription factor 1 expression.
  62. Taylor Jennifer K. ; Cowsert Lex M., Antisense inhibition of fra-1 expression.
  63. Monia Brett P. ; Cowsert Lex M., Antisense inhibition of human Akt-2 expression.
  64. Monia Brett P. ; Cowsert Lex M., Antisense inhibition of human Smad1 expression.
  65. Monia Brett P. ; Cowsert Lex M., Antisense inhibition of human mek1 expression.
  66. Bennett C. Frank ; Monia Brett P. ; Cowsert Lex M., Antisense inhibition of integrin beta 3 expression.
  67. Monia Brett P. ; Wyatt Jacqueline, Antisense inhibition of methionine aminopeptidase 2 expression.
  68. Baker Brenda F. ; Cowsert Lex M., Antisense inhibition of rank expression.
  69. Monia Brett P. ; Basilion James P. ; Stanton ; Jr. Vincent P., Antisense inhibition of replication protein a p70 subunit.
  70. Bennett, C. Frank; Watt, Andrew T., Antisense inhibition of src-c expression.
  71. Monia Brett P. ; Gaarde William A. ; Wancewicz Edward, Antisense inhibition of tert expression.
  72. Nicholas M. Dean ; Susan F. Murray, Antisense inhibition of transforming growth factor-.beta. expression.
  73. Flournoy Shin Cheng ; Bennett C. Frank, Antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression.
  74. Bennett, C. Frank; Watt, Andrew T., Antisense inhibition of vascular endothelial growth factor receptor-1 expression.
  75. Safe, Stephen H.; Chintharlapalli, Sudhakar; Talcott, Susanne U., Antisense microRNA and uses therefor.
  76. Condon Thomas P. ; Flournoy Shin Cheng, Antisense modulation of ADAM10 expression.
  77. Zhang, Hong; Watt, Andrew T., Antisense modulation of BCL2-associated X protein expression.
  78. Zhang, Hong; Wyatt, Jacqueline, Antisense modulation of BH3 interacting domain death agonist expression.
  79. Lex M. Cowsert ; Susan M. Freier, Antisense modulation of BTAK expression.
  80. Crooke, Rosanne M.; Graham, Mark J., Antisense modulation of C-reactive protein expression.
  81. Crooke, Rosanne M.; Graham, Mark J., Antisense modulation of C-reactive protein expression.
  82. Crooke, Rosanne M.; Graham, Mark J., Antisense modulation of C-reactive protein expression.
  83. Crooke,Rosanne M.; Graham,Mark J., Antisense modulation of C-reactive protein expression.
  84. Dobie, Kenneth W., Antisense modulation of CD36L 1 expression.
  85. Bennett, C. Frank; Cowsert, Lex M.; Siwkowski, Andrew M., Antisense modulation of CD40 expression.
  86. Bennett C. Frank ; Cowsert Lex M., Antisense modulation of CD44 expression.
  87. Lex M. Cowsert, Antisense modulation of CHK2 expression.
  88. Bennett, C. Frank; Freier, Susan M., Antisense modulation of CoREST expression.
  89. Wyatt, Jacqueline, Antisense modulation of EDG1 expression.
  90. Dean, Nicholas M.; Marcusson, Eric G.; Wyatt, Jacqueline, Antisense modulation of Fas mediated signaling.
  91. Freier, Susan M.; Bhanot, Sanjay, Antisense modulation of GCCR expression.
  92. Freier, Susan M.; Bhanot, Sanjay, Antisense modulation of GCCR expression.
  93. Freier, Susan M.; Bhanot, Sanjay, Antisense modulation of GCGR expression.
  94. Freier, Susan M.; Bhanot, Sanjay, Antisense modulation of GCGR expression.
  95. C. Frank Bennett ; Harris Busch ; Jacqueline Wyatt, Antisense modulation of GU protein expression.
  96. Bennett C. Frank ; Cowsert Lex M., Antisense modulation of Her-3 expression.
  97. Bennett, C. Frank; Freier, Susan M., Antisense modulation of IL-1 receptor-associated kinase-4 expression.
  98. Jacqueline Wyatt, Antisense modulation of MEKK3 expression.
  99. Monia Brett P. ; Gaarde William ; Cowsert Lex M., Antisense modulation of MEKK5 expression.
  100. Weber Michael J. ; Wyatt Jacqueline ; Cowsert Lex M., Antisense modulation of MP-1 expression.
  101. Ward Donna T. ; Cowsert Lex M., Antisense modulation of NCK-2 expression.
  102. Bennett, C. Frank; Monia, Brett P.; Cowsert, Lex M., Antisense modulation of NF-kappa-B p65 subunit expression.
  103. Monia Brett P. ; Cowsert Lex M., Antisense modulation of PI3 kinase p110 beta expression.
  104. Monia Brett P. ; Cowsert Lex M., Antisense modulation of PKA catalytic subunit C-alpha expression.
  105. Watt, Andrew T., Antisense modulation of PLML expression.
  106. Freier, Susan M., Antisense modulation of PPP3R1 expression.
  107. Bhanot, Sanjay; Cowsert, Lex M.; Wyatt, Jacqueline R.; Monia, Brett P.; Butler, Madeline M.; McKay, Robert; Freier, Susan M.; Dobie, Kenneth W., Antisense modulation of PTP1B expression.
  108. Bhanot, Sanjay; Cowsert, Lex M.; Wyatt, Jacqueline R.; Monia, Brett P.; Butler, Madelline M.; McKay, Robert; Freier, Susan M.; Dobie, Kenneth W., Antisense modulation of PTP1B expression.
  109. Bhanot, Sanjay; Freier, Susan M., Antisense modulation of PTP1B expression.
  110. Bhanot, Sanjay; Freier, Susan M., Antisense modulation of PTP1B expression.
  111. Bhanot, Sanjay; Freier, Susan M., Antisense modulation of PTP1B expression.
  112. Cowsert Lex M. ; Wyatt Jacqueline, Antisense modulation of PTP1B expression.
  113. Cowsert, Lex M.; Wyatt, Jacqueline R.; Freier, Susan M.; Monia, Brett P.; Butler, Madeline M.; McKay, Robert, Antisense modulation of PTP1B expression.
  114. Cowsert, Lex M.; Wyatt, Jacqueline; Monia, Brett P.; Butler, Madeline M.; McKay, Robert, Antisense modulation of PTP1B expression.
  115. Cowsert,Lex M.; Wyatt,Jacqueline R., Antisense modulation of PTP1B expression.
  116. Cowsert, Lex M.; Dobie, Kenneth W., Antisense modulation of PTPN12 expression.
  117. Donna T. Ward ; Andrew T. Watt, Antisense modulation of RECQL2 expression.
  118. Jacqueline Wyatt, Antisense modulation of SR-CYP expression.
  119. Bennett C. Frank ; Cowsert Lex M., Antisense modulation of SRC-1 expression.
  120. Cowsert, Lex M., Antisense modulation of Smad6 expression.
  121. Brett P. Monia ; William A. Gaarde ; Susan M. Freier ; Edward Wancewicz, Antisense modulation of TERT expression.
  122. Donna T. Ward ; Andrew T. Watt, Antisense modulation of WRN expression.
  123. Crooke,Rosanne M.; Graham,Mark J.; Tarbet,Kristina Lemonidis, Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression.
  124. Crooke,Rosanne M.; Tarbet,Kristina Lemonidis; Graham,Mark J., Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression.
  125. Kumar Vijaya B., Antisense modulation of amyloid beta protein expression.
  126. Crooke,Rosanne M.; Graham,Mark J., Antisense modulation of apolipoprotein (a) expression.
  127. Crooke, Rosanne M.; Graham, Mark J., Antisense modulation of apolipoprotein B expression.
  128. Crooke, Rosanne M.; Graham, Mark J., Antisense modulation of apolipoprotein B expression.
  129. Crooke, Rosanne M.; Graham, Mark J., Antisense modulation of apolipoprotein B expression.
  130. Crooke,Rosanne M.; Graham,Mark J., Antisense modulation of apolipoprotein B expression.
  131. Crooke,Roseanne M.; Graham,Mark; Freier,Susan M., Antisense modulation of apolipoprotein B expression.
  132. Crooke, Rosanne M.; Graham, Mark J.; Freier, Susan M., Antisense modulation of apolipoprotein B-expression.
  133. Crooke, Rosanne M.; Graham, Mark J.; Freier, Susan M., Antisense modulation of apolipoprotein B-expression.
  134. Crooke,Rosanne M.; Graham,Mark J., Antisense modulation of c-reactive protein expression.
  135. C. Frank Bennett ; Lex M. Cowsert, Antisense modulation of calreticulin expression.
  136. Robert McKay ; Susan M. Freier ; Jacqueline Wyatt, Antisense modulation of casein kinase 2-alpha prime expression.
  137. Watt, Andrew T., Antisense modulation of caspase 6 expression.
  138. Zhang Hong ; Cowsert Lex M., Antisense modulation of caspase 8 expression.
  139. Andrew T. Watt, Antisense modulation of caspase 9 expression.
  140. Susan M. Freier, Antisense modulation of cellular apoptosis susceptibility gene expression.
  141. Popoff, Ian; Wyatt, Jacqueline, Antisense modulation of damage-specific DNA binding protein 1, p127 expression.
  142. Ian Popoff ; Jacqueline Wyatt, Antisense modulation of damage-specific DNA binding protein 2, p48 expression.
  143. Monia, Brett P.; Watt, Andrew T., Antisense modulation of dual specific phosphatase 5 expression.
  144. Lex M. Cowsert, Antisense modulation of dual specific phosphatase 8 expression.
  145. Dobie, Kenneth W.; Roach, Mark P., Antisense modulation of estrogen receptor alpha expression.
  146. Freier, Susan M., Antisense modulation of fibroblast growth factor receptor 2 expression.
  147. Bhanot, Sanjay; Yu, Xing Xian; McCaleb, Michael L., Antisense modulation of fibroblast growth factor receptor 4 expression.
  148. Bhanot, Sanjay; Yu, Xing-Xian; Freier, Susan M.; Jain, Ravi, Antisense modulation of fibroblast growth factor receptor 4 expression.
  149. Bhanot, Sanjay; Yu, Xing-Xian; Freier, Susan M.; Jain, Ravi, Antisense modulation of fibroblast growth factor receptor 4 expression.
  150. Bennett C. Frank ; Wyatt Jacqueline, Antisense modulation of glioma-associated oncogene-1 expression.
  151. C. Frank Bennett ; Susan M. Freier, Antisense modulation of glioma-associated oncogene-2 expression.
  152. Ward,Donna T.; Watt,Andrew T., Antisense modulation of helicase-moi expression.
  153. Freier, Susan M., Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression.
  154. Brenda F. Baker ; C. Frank Bennett ; Jacqueline Wyatt, Antisense modulation of inhibitor of DNA binding-1 expression.
  155. Brenda F. Baker ; Susan M. Freier, Antisense modulation of interleukin 12 p35 subunit expression.
  156. Dobie, Kenneth W.; Koller, Erich, Antisense modulation of kinesin-like 1 expression.
  157. Dobie, Kenneth W.; Koller, Erich, Antisense modulation of kinesin-like 1 expression.
  158. Dobie, Kenneth W.; Koller, Erich; Jain, Ravi, Antisense modulation of kinesin-like 1 expression.
  159. Dobie,Kenneth W.; Koller,Erich, Antisense modulation of kinesin-like 1 expression.
  160. Dobie,Kenneth W.; Koller,Erich, Antisense modulation of kinesin-like 1 expression.
  161. Murray Susan ; Cowsert Lex M. ; Wyatt Jacqueline, Antisense modulation of macrophage migration inhibitory factor expression.
  162. Crooke, Rosanne M.; Graham, Mark J., Antisense modulation of microsomal triglyceride transfer protein expression.
  163. Dobie, Kenneth W., Antisense modulation of mucin 1, transmembrane expression.
  164. Bennett C. Frank ; Cowsert Lex M., Antisense modulation of nucleolin expression.
  165. Monia, Brett P.; Dobie, Kenneth W.; Freier, Susan M.; Popoff, Ian; Karras, James G., Antisense modulation of p38 mitogen activated protein kinase expression.
  166. C. Frank Bennett ; Susan M. Freier ; Andrew T. Watt, Antisense modulation of phospholipase A2, group VI (Ca2+-independent) expression.
  167. Jacqueline Wyatt, Antisense modulation of phosphorylase kinase alpha 1 expression.
  168. Wyatt, Jacqueline, Antisense modulation of protein phosphatase 2 catalytic subunit beta expression.
  169. Watt, Andrew T., Antisense modulation of raidd expression.
  170. Bennett, C. Frank; Freier, Susan M., Antisense modulation of sphingosine-1-phosphate lyase expression.
  171. Karras James G., Antisense modulation of stat3 expression.
  172. Crooke,Rosanne M.; Graham,Mark J., Antisense modulation of stearoyl-CoA desaturase expression.
  173. Bennett, C. Frank; Dobie, Kenneth W., Antisense modulation of superoxide dismutase 1, soluble expression.
  174. Bennett, C. Frank; Dobie, Kenneth W.; Freier, Susan M.; Condon, Thomas P.; Jain, Ravi; Smith, Richard Alan; Cleveland, Don W., Antisense modulation of superoxide dismutase 1, soluble expression.
  175. Bennett, C. Frank; Freier, Susan M.; Condon, Thomas P., Antisense modulation of superoxide dismutase 1, soluble expression.
  176. Bennett,C. Frank; Dobie,Kenneth, Antisense modulation of superoxide dismutase 1, soluble expression.
  177. Bennett, C. Frank; Swayze, Eric E.; Ackermann, Elizabeth J.; Cowsert, Lex M., Antisense modulation of survivin expression.
  178. Bennett,C. Frank; Ackermann,Elizabeth J.; Cowsert,Lex M., Antisense modulation of survivin expression.
  179. Freier, Susan M.; Wyatt, Jacqueline, Antisense modulation of syntaxin 4 interacting protein expression.
  180. C. Frank Bennett ; Lex M. Cowsert, Antisense modulation of talin expression.
  181. Monia, Brett P.; Freier, Susan M., Antisense modulation of transforming growth factor-beta 3 expression.
  182. C. Frank Bennett ; Andrew T. Watt, Antisense modulation of tumor necrosis factor receptor 2 expression.
  183. Bennett, C. Frank; Watt, Andrew T., Antisense modulation of vascular endothelial growth factor receptor-2 expression.
  184. Wilton, Stephen Donald; Fletcher, Sue; Adams, Abbie; Meloni, Penny, Antisense molecules and methods for treating pathologies.
  185. McKay, Robert; Dean, Nicholas M.; Monia, Brett P.; Nero, Pamela; Gaarde, William A., Antisense oligonucleotide compositions and methods for the modulation of JNK proteins.
  186. Honkanen, Richard E.; Dean, Nicholas M., Antisense oligonucleotide inhibition of human serine/threonine protein phosphatase gene expression.
  187. Karras, James G., Antisense oligonucleotide modulation of STAT3 expression.
  188. Karras, James G., Antisense oligonucleotide modulation of STAT3 expression.
  189. Karras, James G., Antisense oligonucleotide modulation of STAT3 expression.
  190. Karras,James G., Antisense oligonucleotide modulation of STAT3 expression.
  191. Karras,James G., Antisense oligonucleotide modulation of STAT3 expression.
  192. Schlingensiepen, Karl Hermann; Brysch, Wolfgang, Antisense oligonucleotide preparation method.
  193. Schlingensiepen, Karl-Hermann; Brysch, Wolfgang, Antisense oligonucleotide preparation method.
  194. Peyman, Anuschirwan; Uhlmann, Eugen; Weiser, Caroline, Antisense oligonucleotides against tenascin for treating vitiligo.
  195. Dean, Nicholas M.; Foulkes, J. Gordon; O'Donnell, Niall; Bennett, C. Frank; Freier, Susan M., Antisense oligonucleotides directed against connective tissue growth factor and uses thereof.
  196. Dean, Nicholas M.; Foulkes, J. Gordon; O'Donnell, Niall; Bennett, C. Frank; Frier, Susan M., Antisense oligonucleotides directed against connective tissue growth factor and uses thereof.
  197. Dean, Nicholas M.; Foulkes, J. Gordon; O'Donnell, Niall; Bennett, C. Frank; Frier, Susan M., Antisense oligonucleotides directed against connective tissue growth factor and uses thereof.
  198. LaBarbera,Andrew R.; Wang,YiFang; Zhu,ChangHong, Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use.
  199. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  200. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  201. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  202. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  203. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  204. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  205. Wilton, Stephen Donald; Fletcher, Sue; McClorey, Graham, Antisense oligonucleotides for inducing exon skipping and methods of use thereof.
  206. Liang,Chun; Feng,Dao rong; Yu,Zhi ling, Antisense oligonucleotides targeted to human CDC45.
  207. Raoof, Araz A.; Gudipati, Mangaraju; Bibby, David C.; Weinbach, Susan, Antisense permeation enhancers.
  208. Gleave,Martin; Miyake,Hideaki, Antisense therapy for hormone-regulated tumors.
  209. Martin,Gleave; Miyake,Hideaki, Antisense therapy for hormone-regulated tumors.
  210. C. Frank Bennett ; Lex M. Cowsert, Antisenses inhibition of SRC-2 expression.
  211. Gorenstein,David G.; Yang,Xianbin; Luxon,Bruce A.; Herzog,Norbert, Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries.
  212. Gleave, Martin; Pollak, Michael N.; Leavitt, Randy J., Bispecific oligonucleotide for the treatment of CNS malignancies.
  213. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen; Zellweger, Tobias, Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides.
  214. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen; Zellweger, Tobias, Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides.
  215. Gleave, Martin; Rennie, Paul S.; Miyake, Hikeaki; Nelson, Colleen; Zellweger, Tobias, Chemo-and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides.
  216. Innis, Michael A.; Reinhard, Christoph J.; Zuckermann, Ronald N., Chimeric antisense oligonucleotides and cell transfecting formulations thereof.
  217. Crooke, Stanley T., Chimeric oligomeric compounds and their use in gene modulation.
  218. Gleave, Martin E.; Cormack, Scott D., Clusterin antisense therapy for treatment of cancer.
  219. Gleave, Martin E.; Cormack, Scott D., Clusterin antisense therapy for treatment of cancer.
  220. Graff, Jeremy Richard, Combination therapy for the treatment of cancer.
  221. Draper Kenneth G. ; Kisner Daniel L. ; Anderson Kevin P. ; Chapman Sharon, Composition and method for treatment of CMV infections.
  222. Bennett, Clarence Frank; Ecker, David J.; Cook, Phillip Dan, Composition and methods for the pulmonary delivery of nucleic acids.
  223. Kmiec,Eric B.; Rice,Michael C.; Liu,Li, Compositions and methods for enhancing oligonucleotide-mediated gene alteration.
  224. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Compositions and methods for modulating HBV expression.
  225. Rigo, Frank; Freier, Susan M., Compositions and methods for modulating Tau expression.
  226. Kay, Mark A.; Haussecker, Dirk; Cao, Dan, Compositions and methods for modulating activity of capped small RNAS.
  227. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E.; Freier, Susan M.; Graham, Mark J.; Crooke, Rosanne M., Compositions and methods for modulating angiopoietin-like 3 expression.
  228. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E.; Graham, Mark J., Compositions and methods for modulating apolipoprotein (a) expression.
  229. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E.; Graham, Mark J., Compositions and methods for modulating apolipoprotein C-III expression.
  230. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E.; Bhanot, Sanjay; Freier, Susan M.; Bui, Huynh-Hoa, Compositions and methods for modulating growth hormone receptor expression.
  231. Freier, Susan M., Compositions and methods for modulation of Mcl-1 expression.
  232. Baker, Brenda F.; Krainer, Adrian R.; Hua, Yimin, Compositions and methods for modulation of SMN2 splicing.
  233. Baker, Brenda F.; Krainer, Adrian R.; Hua, Yimin, Compositions and methods for modulation of SMN2 splicing.
  234. Bennett, C. Frank; Hung, Gene; Rigo, Frank, Compositions and methods for modulation of SMN2 splicing in a subject.
  235. Bennett, C. Frank; Hung, Gene; Rigo, Frank; Krainer, Adrian R.; Hua, Yimin; Passini, Marco A.; Shihabuddin, Lamya; Cheng, Seng H.; Klinger, Katherine W., Compositions and methods for modulation of SMN2 splicing in a subject.
  236. Bennett, C. Frank; Hung, Gene; Rigo, Frank; Krainer, Adrian R.; Hua, Yimin; Passini, Marco A.; Shihabuddin, Lamya; Cheng, Seng H.; Klinger, Katherine W., Compositions and methods for modulation of SMN2 splicing in a subject.
  237. Teng, Ching-Leou; Cook, Phillip Dan; Tillman, Lloyd; Hardee, Gregory E.; Ecker, David J.; Manoharan, Muthiah, Compositions and methods for non-parenteral delivery of oligonucleotides.
  238. Teng, Ching-Leou; Cook, Phillip Dan; Tillman, Lloyd; Hardee, Gregory E.; Ecker, David J.; Manoharan, Muthiah, Compositions and methods for non-parenteral delivery of oligonucleotides.
  239. Yu, Xing-Xian; Bhanot, Sanjay, Compositions and methods for the modulation of JNK proteins.
  240. Crooke,Stanley T.; Ecker,David J.; Sampath,Rangarajan; Freier,Susan M.; Massire,Christian; Hofstadler,Steven A.; Lowery,Kristin Sannes; Swayze,Eric E.; Baker,Brenda F.; Bennett,C. Frank, Compositions and methods for the treatment of severe acute respiratory syndrome (SARS).
  241. Trieu, Vuong, Compositions and methods for treating pancreatic cancer.
  242. Trieu, Vuong, Compositions and methods for treating pancreatic cancer.
  243. Wedel, Mark K.; Miner, Phillip B., Compositions and methods for treatment of pouchitis.
  244. Gleave, Martin E.; Rocchi, Palma; Signaevsky, Maxim; Beraldi, Eliana, Compositions and methods for treatment of prostate and other cancers.
  245. Gleave, Martin E.; Rocchi, Palma; Signaevsky, Maxim; Beraldi, Eliana, Compositions and methods for treatment of prostate and other cancers.
  246. Gleave, Martin E.; Rocchi, Palma; Signaevsky, Maxim; Beraldi, Eliana, Compositions and methods for treatment of prostate and other cancers.
  247. Gleave, Martin E.; Rocchi, Palma; Signaevsky, Maxim; Beraldi, Eliana, Compositions and methods for treatment of prostate and other cancers.
  248. Gleave, Martin E.; Rocchi, Palma; Signaevsky, Maxim; Beraldi, Eliana, Compositions and methods for treatment of prostate and other cancers.
  249. Gleave, Martin E.; Rocchi, Palma; Signaevsky, Maxim; Beraldi, Eliana, Compositions and methods for treatment of prostate and other cancers.
  250. Gleave, Martin; Rocchi, Palma; Signaevsky, Maxim; Beraldi, Eliana, Compositions and methods for treatment of prostate and other cancers.
  251. Gleave, Martin; Rocchi, Palma; Signaevsky, Maxim; Beraldi, Eliana, Compositions and methods for treatment of prostate and other cancers.
  252. Gleave, Martin; Rocchi, Palma; Signaevsky, Maxim; Beraldi, Eliana, Compositions and methods for treatment of prostate and other cancers.
  253. Gleave,Martin E.; Rocchi,Palma; Signaevsky,Maxim; Beraldi,Eliana, Compositions and methods for treatment of prostate and other cancers.
  254. Podhajcer,Osvaldo Luis; Ledda,Maria Fernanda; Adris,Soraya Karina; Bravo,Alicia Ines; Mordoh,Jose; Chernajovsky,Yuti, Compositions and methods for tumour therapy.
  255. Sacks, Frank M.; Tribble, Diane, Compositions and methods of targeting apolipoprotein B for the reduction of apolipoprotein C-III.
  256. Barrett, Alan; Beasley, David; Holbrook, Michael, Compositions and methods related to flavivirus envelope protein domain III antigens.
  257. Dobie, Kenneth W.; Freier, Susan M., Compositions and their uses directed to Gemin Genes.
  258. Dobie, Kenneth W.; Dean, Nicholas M.; Bennett, C. Frank, Compositions and their uses directed to HBXIP.
  259. Karras, James G.; Gregory, Susan; Crosby, Jeffrey R.; Guha, Mausumee; Tung, David; Freier, Susan M., Compositions and their uses directed to IL-4R alpha.
  260. Bhanot, Sanjay; Murray, Susan F., Compositions and their uses directed to PTPR alpha.
  261. McKay, Robert; Jain, Ravi; Dobie, Kenneth W.; Pandey, Sanjay K.; Bhanot, Sanjay, Compositions and their uses directed to PTPRU.
  262. McKay, Robert; Jain, Ravi; Dobie, Kenneth W.; Pandey, Sanjay K.; Bhanot, Sanjay, Compositions and their uses directed to PTPRU.
  263. Bhanot, Sanjay; Monia, Brett P.; Geisler, John G.; McKay, Robert; Dobie, Kenneth W., Compositions and their uses directed to acetyl-CoA carboxylases.
  264. Yu, Xing-Xian; Bhanot, Sanjay; Monia, Brett P., Compositions and their uses directed to diacylglycerol acyltransferase 1.
  265. Yu, Xing-Xian; Bhanot, Sanjay; Monia, Brett P., Compositions and their uses directed to diacylglycerol acyltransferase 1.
  266. Dobie, Kenneth W.; Freier, Susan M., Compositions and their uses directed to gemin genes.
  267. Monia, Brett P.; Bennett, C. Frank; Gaarde, William A.; Lockhart, Trisha; McKay, Robert, Compositions and their uses directed to hepcidin.
  268. Freier, Susan M., Compositions and their uses directed to huntingtin.
  269. Freier, Susan M., Compositions and their uses directed to huntingtin.
  270. Freier, Susan M., Compositions and their uses directed to huntingtin.
  271. Hung, Gene; Leeds, Janet M.; Bennett, C. Frank; Freier, Susan M., Compositions and their uses directed to huntingtin.
  272. Karras, James G.; Dobie, Kenneth W., Compositions and their uses directed to thymus and activation-regulated chemokine (TARC).
  273. Allerson, Charles; Bhat, Balkrishen; Eldrup, Anne B.; Manoharan, Muthiah; Griffey, Richard H.; Baker, Brenda F.; Swayze, Eric E., Compositions comprising alternating 2′-modified nucleosides for use in gene modulation.
  274. Freier, Susan M.; Rigo, Frank, Compositions for modulating C9ORF72 expression.
  275. Rigo, Frank, Compositions for modulating C9ORF72 expression.
  276. Freier, Susan M., Compositions for modulating Tau expression.
  277. Taffy Williams ; George Tuszynski ; Paul Actor, Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions.
  278. Kaye, Edward M., Compositions for treating muscular dystrophy.
  279. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression ApoB.
  280. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of DGAT2.
  281. Bhanot, Sanjay; Geary, Richard; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of GCCR.
  282. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of GCGR.
  283. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric; Wancewicz, Edward, Compounds and methods for modulating expression of PCSK9.
  284. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of PTP1B.
  285. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of SGLT2.
  286. Bennett, C. Frank; McKay, Robert; Monia, Brett P.; Baker, Brenda F.; Sioufi, Namir, Conjugates for use in hepatocyte free uptake assays.
  287. Graham, Michael Wayne; Rice, Robert Norman, Control of gene expression.
  288. Graham, Michael Wayne; Rice, Robert Norman, Control of gene expression.
  289. Graham, Michael Wayne; Rice, Robert Norman; Waterhouse, Peter Michael, Control of gene expression.
  290. Rohloff, John; Janjic, Nebojsa; Gawande, Bharat Nathu, Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto.
  291. Rohloff, John; Janjic, Nebojsa; Gawande, Bharat Nathu, Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto.
  292. Monia, Brett P.; Freier, Susan M.; Siwkowski, Andrew M.; Guo, Shuling, Diagnosis and treatment of disease.
  293. Baker, Brenda F.; Kraynack, Bryan A., Double stranded constructs comprising one or more short strands hybridized to a longer strand.
  294. Rossi, John J.; Castanotto, Daniela; Pfeifer, Gerd; Tommasi, Stella; Morris, Kevin V.; Kim, Daniel H., Double stranded nucleic acid targeting low copy promoter-specific RNA.
  295. Woolf, Tod, Double-stranded oligonucleotides.
  296. Woolf, Tod; Wiederholt, Kristin, Double-stranded oligonucleotides.
  297. Woolf, Tod; Wiederholt, Kristin, Double-stranded oligonucleotides.
  298. Kmiec, Eric B.; Parekh Olmedo, Hetal; Brachman, Erin E., Enhanced oligonucleotide-mediated nucleic acid sequence alteration.
  299. Riggins,Gregory J.; Lal,Anita; Loging,William T., Four genetic tumor markers specific for human glioblastoma.
  300. Hanson, Gunnar J.; Weller, Dwight D.; Cai, Bao Zhong; Zhou, Ming, Functionally-modified oligonucleotides and subunits thereof.
  301. Hanson, Gunnar J.; Weller, Dwight D.; Cai, Bao Zhong; Zhou, Ming, Functionally-modified oligonucleotides and subunits thereof.
  302. Swayze, Eric E.; Migawa, Michael T.; Wyrzykiewicz, Tadeusz Krzysztof, Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini.
  303. Sanghvi, Yogesh S.; Manoharan, Muthiah, Gapped oligomers having site specific chiral phosphorothioate internucleoside linkages.
  304. Kasid,Usha; Gokhale,Prafulla; Kumar,Deepak; Broustas,Constantinos; Ahmad,Imran; Dritschilo,Anatoly; Rahman,Aquilur, Gene BRCC-2 and diagnostic and therapeutic uses thereof.
  305. Kasid,Usha; Gokhale,Prafulla; Kumar,Deepak; Boudreau,Howard; Ahmad,Imran; Dritschilo,Anatoly; Rahman,Aquilur, Gene BRCC-3 and diagnostic and therapeutic uses thereof.
  306. Kasid,Usha; Kumar,Deepak; Ahmad,Imran, Gene SCC-112 and diagnostic and therapeutic uses thereof.
  307. Kasid,Usha; Sakabe,Isamu; Ahmad,Imran, Gene SHINC-2 and diagnostic and therapeutic uses thereof.
  308. Kasid,Usha; Sakabe,Isamu; Ahmad,Imran, Gene shinc-3 and diagnostic and therapeutic uses thereof.
  309. Baulcombe, David Charles; Hamilton, Andrew John, Gene silencing.
  310. Baulcombe, David Charles; Hamilton, Andrew John, Gene silencing.
  311. Baulcombe, David Charles; Hamilton, Andrew John, Gene silencing.
  312. Baulcombe, David Charles; Hamilton, Andrew John, Gene silencing.
  313. Russell,Paul R.; Vialard,Jorge E.; Boddy,Michael N.; Shanahan,Paul A.; Lopez Girona,Antonia; Denis,Cecile Marie D. D.; McGowan,Clare H., Genes and proteins encoded thereby.
  314. Agrawal,Sudhir, HIV-specific synthetic oligonucleotides and methods of their use.
  315. Georges,Elias; Serfass,Lucile; Bonneau,Anne Marie; Dallaire,Fr?d?ric, HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease.
  316. Brown, David; Ford, Lance P.; Jarvis, Richard A.; Pallotta, Vince; Pasloske, Brittan L., High potency siRNAS for reducing the expression of target genes.
  317. Crooke, Stanley T.; Lima, Walter F.; Wu, Hongjiang; Monoharan, Muthiah, Human Rnase H1 and oligonucleotide compositions thereof.
  318. Tuschl, Thomas; Lagos-Quintana, Mariana; Lendeckel, Winfried; Meyer, Jutta; Rauhut, Reinhard, Identification of novel genes coding for small temporal RNAS.
  319. Tuschl, Thomas; Lagos-Quintana, Mariana; Lendeckel, Winfried; Dammann, Jutta; Rauhut, Reinhard, Identification of novel genes coding for small temporal RNAs.
  320. Tuschl, Thomas; Lagos-Quintana, Mariana; Lendeckel, Winfried; Dammann, Jutta; Rauhut, Reinhard, Identification of novel genes coding for small temporal RNAs.
  321. Tuschl, Thomas; Lagos-Quintana, Mariana; Lendeckel, Winfried; Meyer, Jutta; Rauhut, Reinhard, Identification of novel genes coding for small temporal RNAs.
  322. Perera, Ranjan; Koo, Seongjoon; Dean, Nicholas M.; Marcusson, Eric G., Identification of novel pathways, genes and promoter motifs regulating adipogenesis.
  323. Tachas,George, Inhibition of gastric acid production and/or secretion.
  324. Jensenius, Jens Chr.; Thiel, Steffen, MASP 2, a complement-fixing enzyme, and uses for it.
  325. Jensenius, Jens Chr.; Thiel, Steffen, MASP-2, a complement fixing enzyme, and uses for it.
  326. Korneluk, Robert G.; MacKenzie, Alexander E.; Baird, Stephen; Liston, Peter, Mammalian IAP gene family, primers, probes and detection methods.
  327. Burzio, Luis O.; Villegas, Jaime E.; Burzio, Veronica A., Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein.
  328. Burzio, Luis O.; Villegas, Jaime E.; Burzio, Veronica A., Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein.
  329. Burzio, Luis; Villegas, Jaime E.; Burzio, Veronica A., Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein.
  330. Burzio, Luis; Villegas, Jaime E.; Burzio, Veronica A., Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein.
  331. Kreutzer, Roland; Limmer, Stefan, Method and medicament for inhibiting the expression of a given gene.
  332. Kreutzer, Roland; Limmer, Stefan, Method and medicament for inhibiting the expression of a given gene.
  333. Kreutzer, Roland; Limmer, Stefan, Method and medicament for inhibiting the expression of a given gene.
  334. Kreutzer, Roland; Limmer, Stefan, Method and medicament for inhibiting the expression of a given gene.
  335. Kreutzer, Roland; Limmer, Stefan, Method and medicament for inhibiting the expression of a given gene.
  336. Kreutzer, Roland; Limmer, Stefan, Method and medicament for inhibiting the expression of a given gene.
  337. Kreutzer, Roland; Limmer, Stefan, Method and medicament for inhibiting the expression of a given gene.
  338. Kreutzer, Roland; Limmer, Stefan, Method and medicament for inhibiting the expression of a given gene.
  339. Kreutzer, Roland; Limmer, Stefan, Method and medicament for inhibiting the expression of a given gene.
  340. Kreutzer, Roland; Limmer, Stefan, Method and medicament for inhibiting the expression of a given gene.
  341. Dawson, Elliott P.; Womble, Kristie E., Method and substances for isolating miRNAs.
  342. Dawson, Elliott P.; Womble, Kristie E., Method and substances for isolating miRNAs.
  343. Dawson, Elliott P.; Womble, Kristie E., Method and substances for isolating miRNAs.
  344. Nahas Nasri,FRX ; Dumas Milne Edwards Jean-Baptiste,FRX, Method for eliminating specific sequences when constructing DNA libraries.
  345. Zichi, Dominic; Wilcox, Sheri K.; Bock, Chris; Schneider, Daniel J.; Eaton, Bruce; Gold, Larry, Method for generating aptamers with improved off-rates.
  346. Zichi, Dominic; Wilcox, Sheri K.; Bock, Chris; Schneider, Daniel J.; Eaton, Bruce; Gold, Larry; Jarvis, Thale C.; Carter, Jeffrey D., Method for generating aptamers with improved off-rates.
  347. Zichi, Dominic; Wilcox, Sheri K.; Bock, Chris; Schneider, Daniel J.; Eaton, Bruce; Gold, Larry; Jarvis, Thale C.; Carter, Jeffrey D., Method for generating aptamers with improved off-rates.
  348. Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H., Method for inhibiting the activity of mir-155.
  349. Kreutzer, Roland; Limmer, Stefan, Method for making a 21 nucleotide double stranded RNA chemically linked at one end.
  350. Mustoe, Thomas A.; Dean, Nicholas M.; Sisco, Mark; Kryger, Zol; Bennett, C. Frank, Method for reducing scarring during wound healing using antisense compounds directed to CTGF.
  351. LaCasse, Eric; McManus, Daniel; Durkin, Jon P., Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent.
  352. Stein, David A.; Bestwick, Richard K.; Iversen, Patrick L.; Weller, Dwight D., Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds.
  353. Gaitanaris, George A.; Bergmann, John E.; Gragerov, Alexander; Hohmann, John; Li, Fusheng; Madisen, Linda; McIlwain, Kellie L.; Pavlova, Maria N.; Vassilatis, Demetri; Zeng, Hongkui, Method of identifying a compound for the treatment or prevention of obesity.
  354. Esau, Christine; Lollo, Bridget; Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H.; Baker, Brenda F.; Vickers, Timothy A.; Marcusson, Eric G.; Koller, Erich; Swayze, Eric E.; Jain, Ravi; Bhat, Balkrishen; Peralta, Eigen, Method of inhibiting miR-33 using a modified oligonucleotide.
  355. Nagata,Shigekazu; Yatomi,Takehiro; Suda,Takashi, Method of treating graft versus host disease by administration of a Fas antagonist.
  356. Dean, Nicholas M.; Krochmal, Lincoln; Hardee, Gregory; Foulkes, J. Gordon; O'Donnell, Niall; Young, Leroy; Jewell, Mark, Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (CTGF).
  357. Monia, Brett P.; McCaleb, Michael L.; Freier, Susan M.; Guo, Shuling, Methods and compositions for modulating alpha-1-antitrypsin expression.
  358. Crooke, Rosanne M.; Graham, Mark J.; Freier, Susan M.; Lim, Marc; Dibble, Andrew, Methods and compositions for modulating apolipoprotein (a) expression.
  359. Anil B. Mukherjee ; Gopal C. Kundu IN; Dibyendu K. Panda CA, Methods and compositions for treatment of restenosis.
  360. Kufe, Donald W., Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3.
  361. Kufe, Donald W., Methods and compositions relating to the regulation of apoptosis by MUC1 and BH3-containing proapoptotic proteins.
  362. Waterhouse, Peter Michael; Wang, Ming-Bo, Methods and means for obtaining modified phenotypes.
  363. Waterhouse, Peter Michael; Wang, Ming-Bo, Methods and means for obtaining modified phenotypes.
  364. Waterhouse, Peter Michael; Wang, Ming-Bo, Methods and means for obtaining modified phenotypes.
  365. Waterhouse, Peter Michael; Wang, Ming-Bo; Graham, Michael Wayne, Methods and means for obtaining modified phenotypes.
  366. Waterhouse, Peter Michael; Wang, Ming-Bo; Graham, Michael Wayne; Smith, Neil A., Methods and means for obtaining modified phenotypes.
  367. Waterhouse, Peter; Wang, Ming-Bo, Methods and means for obtaining modified phenotypes.
  368. Dean, Nicholas M.; Foulkes, J. Gordon; O'Donnell, Niall; Bennett, C. Frank; Frier, Susan M., Methods for inhibiting expression of connective tissue growth factor.
  369. Bennett, C. Frank; Freier, Susan M.; Pulst, Stefan M.; Scoles, Daniel R.; Hung, Gene, Methods for modulating Ataxin 2 expression.
  370. Bennett, C. Frank; Freier, Susan M.; Rigo, Frank; Cleveland, Don W.; Lagier-Tourenne, Clotilde; Ravits, John M.; Baughn, Michael W., Methods for modulating C9ORF72 expression.
  371. Monia, Brett P.; Yu, Xing-Xian; Bhanot, Sanjay, Methods for modulating expression of RBP4.
  372. Bhattacharjee, Gourab; Revenko, Alexey; MacLeod, Robert A., Methods for modulating factor 12 expression.
  373. Monia, Brett P.; MacLeod, Robert A.; Crosby, Jeffrey R., Methods for modulating factor 12 expression.
  374. Bhattacharjee, Gourab; Revenko, Alexey; MacLeod, Robert A., Methods for modulating kallikrein (KLKB1) expression.
  375. Revenko, Alexey; Bhattacharjee, Gourab; MacLeod, Robert A., Methods for modulating kallikrein (KLKB1) expression.
  376. Bennett, C. Frank; Freier, Susan M.; Condon, Thomas P., Methods for slowing familial ALS disease progression.
  377. Bennett, C. Frank; Freier, Susan M.; Dobie, Kenneth W., Methods for slowing familial ALS disease progression.
  378. Demopulos, Gregory A.; Dudler, Thomas; Schwaeble, Hans-Wilhelm, Methods for treating conditions associated with MASP-2 dependent complement activation.
  379. Demopulos, Gregory A.; Dudler, Thomas; Schwaeble, Hans-Wilhelm, Methods for treating conditions associated with MASP-2 dependent complement activation.
  380. Demopulos, Gregory A.; Dudler, Thomas; Schwaeble, Hans-Wilhelm, Methods for treating conditions associated with MASP-2 dependent complement activation.
  381. Demopulos, Gregory A.; Dudler, Thomas; Schwaeble, Hans-Wilhelm, Methods for treating conditions associated with MASP-2 dependent complement activation.
  382. Schwaeble, Hans-Wilhelm; Tedford, Clark E.; Parent, James B.; Dudler, Thomas; Demopulos, Gregory A., Methods for treating conditions associated with MASP-2 dependent complement activation.
  383. Schwaeble, Hans-Wilhelm; Dudler, Thomas; Tedford, Clark E.; Parent, James B.; Demopulos, Gregory A., Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation.
  384. Freier, Susan M.; Crooke, Rosanne M.; Graham, Mark J.; Lemonidis, Kristina L.; Bhanot, Sanjay; Tribble, Diane; Watt, Andrew T., Methods for treating hypercholesterolemia.
  385. Freier, Susan M.; Crooke, Rosanne M.; Graham, Mark J.; Lemonidis, Kristina L.; Bhanot, Sanjay; Tribble, Diane; Watt, Andrew T., Methods for treating hypercholesterolemia.
  386. Freier, Susan M.; Crooke, Rosanne M.; Graham, Mark J.; Lemonidis, Kristina M.; Bhanot, Sanjay; Tribble, Diane; Watt, Andrew T., Methods for treating hypercholesterolemia.
  387. Freier, Susan M.; Crooke, Rosanne M.; Graham, Mark J.; Lemonidis, Kristina M.; Bhanot, Sanjay; Watt, Andrew T.; Tribble, Diane, Methods for treating hypercholesterolemia.
  388. Baulcombe, David Charles; Hamilton, Andrew John, Methods of detecting silencing mammalian cells.
  389. Gozes, Illana; Brenneman, Douglas E.; Zamostiano, Rachel; Gelber, Edgar; Pinhasov, Albert; Bassan, Merav, Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides.
  390. Freier, Susan M.; Matveeva, Olga; Tsodikov, Alexander; Giddings, Michael C.; Wyatt, Jacqueline R., Methods of obtaining active antisense compounds.
  391. Freier, Susan M.; Matveeva, Olga; Tsodikov, Alexander; Giddings, Michael C.; Wyatt, Jacqueline R., Methods of obtaining active antisense compounds.
  392. Hung, Gene, Methods of treating kennedy's disease.
  393. Shemi, Amotz, Methods, compositions and systems for local delivery of drugs.
  394. Wang, Shusheng; Olson, Eric; Zhou, Qinbo, Micro-RNAs involved in macular degeneration.
  395. Tuschl, Thomas; Lagos-Quintana, Mariana; Lendeckel, Winfried; Meyer, Jutta; Rauhut, Reinhard, MicroRNA molecules.
  396. Tuschl, Thomas; Lagos-Quintana, Mariana; Lendeckel, Winfried; Meyer, Jutta; Rauhut, Reinhard, MicroRNA molecules.
  397. Tuschl, Thomas; Lagos-Quintana, Mariana; Lendeckel, Winfried; Meyer, Jutta; Rauhut, Reinhard, MicroRNA molecules.
  398. Tuschl, Thomas; Lagos-Quintana, Mariana; Lendeckel, Winfried; Meyer, Jutta; Rauhut, Reinhard, MicroRNA molecules.
  399. Tuschl, Thomas; Lagos-Quintana, Mariana; Lendeckel, Winfried; Meyer, Jutta; Rauhut, Reinhard, MicroRNA molecules.
  400. Tuschl,Thomas; Lagos Quintana,Marina; Lendeckel,Winfried; Meyer,Jutta; Rauhut,Reinhard, MicroRNA molecules.
  401. Tuschl, Thomas; Lagos-Quintana, Mariana; Lendeckel, Winfried; Meyer, Jutta; Rauhut, Reinhard, Microrna molecules.
  402. Tuschl, Thomas; Lagos-Quintana, Mariana; Lendeckel, Winfried; Meyer, Jutta; Rauhut, Reinhard, Microrna molecules.
  403. Vickers, Timothy; Dean, Nicholas M., Modification of MYD88 splicing using modified oligonucleotides.
  404. Vickers, Timothy; Dean, Nicholas M., Modification of MyD88 splicing using modified oligonucleotides.
  405. Behlke, Mark Aaron; Lennox, Kimberly Ann; Jacobi, Ashley Mae; Owczarzy, Richard; Walder, Joseph Alan, Modifications for antisense compounds.
  406. Behlke, Mark Aaron; Owczarzy, Richard; You, Yong; Walder, Joseph Alan; Lennox, Kim, Modifications for antisense compounds.
  407. Behlke, Mark Aaron; Owczarzy, Richard; You, Yong; Walder, Joseph Alan; Lennox, Kim, Modifications for antisense compounds.
  408. Han, Jang; Seo, Mi-Young; Houghton, Michael, Modified small interfering RNA molecules and methods of use.
  409. Crooke, Rosanne M.; Graham, Mark J., Modulation of C-reactive protein expression.
  410. Crooke, Rosanne M.; Graham, Mark J., Modulation of C-reactive protein expression.
  411. Crooke,Rosanne M.; Graham,Mark J., Modulation of C-reactive protein expression.
  412. Bennett, C. Frank; Cowsert, Lex M.; Freier, Susan M., Modulation of CD40 expression.
  413. Bennett, C. Frank; Cowsert, Lex M.; Freier, Susan M., Modulation of CD40 expression.
  414. Freier, Susan M., Modulation of FR-alpha expression.
  415. Marcusson, Eric G.; Henry, Scott W.; Kim, Youngsoo; Dobie, Kenneth W., Modulation of HIF-1 beta expression.
  416. Marcusson, Eric G.; Henry, Scott W.; Kim, Youngsoo; Dobie, Kenneth, Modulation of HIF1-beta expression.
  417. Ward, Donna T.; Dobie, Kenneth W.; Marcusson, Eric G.; Freier, Susan M., Modulation of HIF1α and HIF2α expression.
  418. Swayze, Eric E.; Freier, Susan M.; McCaleb, Michael L.; Zhang, Hong, Modulation of Hepatitis B virus (HBV) expression.
  419. Baker, Brenda F; Bennett, C. Frank; Dobie, Kenneth W.; Myers, Kathleen; Finger, Joshua; Cowsert, Lex M., Modulation of RANKL expression.
  420. Pandey, Sanjay K.; Bhanot, Sanjay; Marcusson, Eric G.; Freier, Susan M., Modulation of SMRT expression.
  421. Shanahan, Jr., William R.; Freier, Susan M.; Dobie, Kenneth W., Modulation of STAT 6 expression.
  422. Freier, Susan M.; Karras, James G., Modulation of STAT5 expression.
  423. Freier,Susan M.; Karras,James, Modulation of STAT5 expression.
  424. Guo, Shuling, Modulation of TMPRSS6 expression.
  425. Rigo, Frank; Ward, Amanda; Meng, Linyan; Beaudet, Arthur L., Modulation of UBE3A-ATS expression.
  426. Freier, Susan M., Modulation of alpha synuclein expression.
  427. Macleod, Robert A.; Kim, Youngsoo; Zhou, Tianyuan; Freier, Susan M.; Monia, Brett, Modulation of androgen receptor expression.
  428. Crooke, Rosanne M.; Graham, Mark J.; Lee, Richard, Modulation of angiopoietin-like 3 expression.
  429. Crooke, Rosanne M.; Graham, Mark J.; Lee, Richard; Dobie, Kenneth W., Modulation of angiopoietin-like 3 expression.
  430. Crooke, Rosanne M.; Graham, Mark J., Modulation of apolipoprotein (A) expression.
  431. Crooke, Rosanne M.; Graham, Mark J., Modulation of apolipoprotein (A) expression.
  432. Crooke, Rosanne M.; Graham, Mark J., Modulation of apolipoprotein (a) expression.
  433. Crooke, Rosanne M.; Graham, Mark J., Modulation of apolipoprotein (a) expression.
  434. Crooke,Rosanne M.; Graham,Mark J., Modulation of apolipoprotein (a) expression.
  435. Alexander, Veronica J.; Viney, Nicholas J.; Witztum, Joseph L., Modulation of apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populations.
  436. Crooke, Rosanne M.; Graham, Mark J.; Lemonidis, Kristina M., Modulation of apolipoprotein C-III expression.
  437. Crooke, Rosanne M.; Graham, Mark J.; Lemonidis, Kristina M.; Dobie, Kenneth W., Modulation of apolipoprotein C-III expression.
  438. Crooke, Rosanne M.; Graham, Mark J.; Lemonidis, Kristina M.; Dobie, Kenneth W., Modulation of apolipoprotein C-III expression.
  439. Mullick, Adam; Crooke, Rosanne M.; Graham, Mark J.; Dobie, Kenneth W.; Lee, Richard, Modulation of apolipoprotein CIII (ApoCIII) expression.
  440. Crooke, Rosanne M.; Graham, Mark J.; Dobie, Kenneth W., Modulation of apolipoprotein c-III expression.
  441. Monia, Brett P.; Graham, Mark J., Modulation of diacylglycerol acyltransferase 1 expression.
  442. Bhanot, Sanjay; Dobie, Kenneth W.; Yu, Xing-Xian; Monia, Brett P., Modulation of diacylglycerol acyltransferase 2 expression.
  443. Bhanot, Sanjay; Dobie, Kenneth W.; Yu, Xing-Xian; Monia, Brett P., Modulation of diacylglycerol acyltransferase 2 expression.
  444. Bhanot, Sanjay; Dobie, Kenneth W.; Yu, Xing-Xian; Monia, Brett P., Modulation of diacylglycerol acyltransferase 2 expression.
  445. Bhanot, Sanjay; Dobie, Kenneth W.; Yu, Xing-Xian; Monia, Brett P., Modulation of diacylglycerol acyltransferase 2 expression.
  446. Bennett, C. Frank; Freier, Susan M.; MacLeod, Robert A.; Pandey, Sanjay K.; Thornton, Charles A.; Wheeler, Thurman; Cheng, Seng H.; Leger, Andrew; Wentworth, Bruce M., Modulation of dystrophia myotonica-protein kinase (DMPK) expression.
  447. Dobie, Kenneth W.; Marcusson, Eric G.; Swayze, Eric E.; Bhat, Balkrishen; Graff, Jeremy Richard, Modulation of eIF4E expression.
  448. Monia, Brett P.; Bhanot, Sanjay; Dobie, Kenneth W.; Jain, Ravi, Modulation of eIF4E-BP1 expression.
  449. Dobie,Kenneth W., Modulation of endothelial lipase expression.
  450. Freier, Susan M.; Glass, Christopher K.; Rosenfeld, Michael G.; Li, Wenbo; Lam, Michael T., Modulation of enhancer RNA mediated gene expression.
  451. Freier, Susan M.; Monia, Brett P.; Zhang, Hong; Zhao, Chenguang; Crosby, Jeffrey R.; Siwkowski, Andrew M., Modulation of factor 11 expression.
  452. Freier, Susan M.; Monia, Brett P.; Zhang, Hong; Zhao, Chenguang; Crosby, Jeffrey R.; Siwkowski, Andrew M., Modulation of factor 11 expression.
  453. Freier, Susan M.; Monia, Brett P.; Zhang, Hong; Crosby, Jeffrey R.; Zhao, Chenguang, Modulation of factor 7 expression.
  454. Dobie, Kenneth W.; Bhanot, Sanjay; McKay, Robert; Pandey, Sanjay K., Modulation of forkhead box O1A expression.
  455. Dobie, Kenneth W.; Bhanot, Sanjay; McKay, Robert; Pandey, Sanjay K., Modulation of forkhead box O1A expression.
  456. Dobie, Kenneth W.; Bhanot, Sanjay; Veniant-Ellison, Murielle; Lindberg, Richard A.; Shutter, John R.; McKay, Robert; Pandey, Sanjay K., Modulation of forkhead box O1A expression.
  457. Dobie,Kenneth W.; Bhanot,Sanjay; Veniant Ellison,Murielle; Lindberg,Richard A.; Shutter,John R., Modulation of forkhead box O1A expression.
  458. Freier, Susan M., Modulation of glucagon receptor expression.
  459. Freier, Susan M.; Dobie, Kenneth W.; McKay, Robert; Bhanot, Sanjay, Modulation of glucagon receptor expression.
  460. Freier,Susan M.; Dobie,Kenneth W.; Bhanot,Sanjay; McKay,Robert, Modulation of glucagon receptor expression.
  461. Bhanot, Sanjay, Modulation of glucose-6-phosphatase translocase expression.
  462. Dobie, Kenneth W; Jain, Ravi, Modulation of growth hormone receptor expression and insulin-like growth factor expression.
  463. Dobie, Kenneth; Jain, Ravi, Modulation of growth hormone receptor expression and insulin-like growth factor expression.
  464. Tachas, George, Modulation of growth hormone receptor expression and insulin-like growth factor expression.
  465. Tachas, George, Modulation of growth hormone receptor expression and insulin-like growth factor expression.
  466. Tachas, George; Dobie, Kenneth W; Jain, Ravi; Belyea, Christopher I; Heffernan, Mark A, Modulation of growth hormone receptor expression and insulin-like growth factor expression.
  467. Tachas, George; Dobie, Kenneth; Jain, Ravi; Belyea, Christopher; Heffernan, Mark, Modulation of growth hormone receptor expression and insulin-like growth factor expression.
  468. Tachas, George; Dobie, Kenneth; Jain, Ravi; Belyea, Christopher; Heffernan, Mark, Modulation of growth hormone receptor expression and insulin-like growth factor expression.
  469. Freier, Susan M., Modulation of hepatitis B virus (HBV) expression.
  470. Swayze, Eric E.; Freier, Susan M.; McCaleb, Michael L., Modulation of hepatitis B virus (HBV) expression.
  471. Swayze, Eric E.; Freier, Susan M.; McCaleb, Michael L., Modulation of hepatitis B virus (HBV) expression.
  472. Hung, Gene; Bennett, C. Frank; Freier, Susan M.; Kordasiewicz, Holly; Stanek, Lisa; Cleveland, Don W.; Cheng, Seng H.; Shihabuddin, Lamya, Modulation of huntingtin expression.
  473. Hung, Gene; Bennett, C. Frank; Freier, Susan M.; Kordasiewicz, Holly; Stanek, Lisa; Cleveland, Don W.; Cheng, Seng H.; Shihabuddin, Lamya, Modulation of huntingtin expression.
  474. Hung, Gene; Bennett, C. Frank; Freier, Susan M.; Kordasiewicz, Holly; Stanek, Lisa; Cleveland, Don W.; Cheng, Seng H.; Shihabuddin, Lamya, Modulation of huntingtin expression.
  475. Dobie, Kenneth W., Modulation of insulin like growth factor I receptor expression.
  476. Wraight,Cristopher John; Werther,George Arthur; Dean,Nicholas M.; Dobie,Kenneth W., Modulation of insulin like growth factor I receptor expression.
  477. Agrawal, Sudhir, Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides.
  478. Agrawal,Sudhir; Kandimalla,Ekambar R., Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides.
  479. Freier, Susan M.; Bui, Huynh-Hoa, Modulation of prekallikrein (PKK) expression.
  480. Bennett, C. Frank; Hung, Gene; Freier, Susan M.; Dobie, Kenneth W., Modulation of prion expression.
  481. Swayze, Eric E.; Freier, Susan M.; MacLeod, Robert A.; Kim, Youngsoo, Modulation of signal transducer and activator of transcription 3 (STAT3) expression.
  482. Swayze, Eric E.; Freier, Susan M.; MacLeod, Robert A.; Kim, Youngsoo, Modulation of signal transducer and activator of transcription 3 (STAT3)expression.
  483. Freier, Susan M.; Karras, James G., Modulation of stat5 expression.
  484. Freier, Susan M.; Karras, James G., Modulation of stat5 expression.
  485. Ward, Donna T.; Watt, Andrew T., Modulation of the RNA interference pathway.
  486. Kharbanda, Surender; Kufe, Donald W., Modulation of the interaction of MUC1 with MUC1 ligands.
  487. Brown-Driver, Vickie L.; Jain, Ravi, Modulation of transthyretin expression.
  488. Freier, Susan M., Modulation of transthyretin expression.
  489. Monia, Brett P.; Freier, Susan M.; Siwkowski, Andrew M.; Guo, Shuling, Modulation of transthyretin expression.
  490. Sazani, Peter; Kole, Ryszard, Multiple exon skipping compositions for DMD.
  491. Sazani, Peter; Kole, Ryszard, Multiple exon skipping compositions for DMD.
  492. Sazani, Peter; Kole, Ryszard, Multiple exon skipping compositions for DMD.
  493. Sazani, Peter; Kole, Ryszard, Multiple exon skipping compositions for DMD.
  494. Schneider, Daniel J.; Nieuwlandt, Dan; Eaton, Bruce; Stanton, Martin; Gupta, Shashi; Kraemer, Stephan; Zichi, Dominic; Gold, Larry, Multiplexed analyses of test samples.
  495. Wright,Jim A.; Young,Aiping H.; Lee,Yoon S., Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth.
  496. Reddy, Ramachandra; Gill, Parkash, Nucleic acid compounds for inhibiting angiogenesis and tumor growth.
  497. Georges,Elias; Serfass,Lucile; Bonneau,Anne Marie; Dallaire,Fr��d��ric, Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease.
  498. Lollo, Bridget; Jain, Ravi, Oligomeric compounds and compositions for use in modulation of pri-miRNAs.
  499. Lollo, Bridget; Jain, Ravi, Oligomeric compounds and compositions for use in modulation of pri-mirnas.
  500. Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H., Oligomeric compounds and compositions for use in modulation of small non-coding RNAS.
  501. Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H., Oligomeric compounds and compositions for use in modulation of small non-coding RNAS.
  502. Gordon, Bridget; Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H.; Swayze, Eric E.; Jain, Ravi; Bhat, Balkrishen, Oligomeric compounds and compositions for use in modulation of small non-coding RNAS.
  503. Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H., Oligomeric compounds and compositions for use in modulation of small non-coding RNAs.
  504. Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H., Oligomeric compounds and compositions for use in modulation of small non-coding RNAs.
  505. Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H., Oligomeric compounds and compositions for use in modulation of small non-coding RNAs.
  506. Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H., Oligomeric compounds and compositions for use in modulation of small non-coding RNAs.
  507. Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H., Oligomeric compounds and compositions for use in modulation of small non-coding RNAs.
  508. Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H., Oligomeric compounds and compositions for use in modulation of small non-coding RNAs.
  509. Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H., Oligomeric compounds and compositions for use in modulation of small non-coding RNAs.
  510. Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H., Oligomeric compounds and compositions for use in modulation of small non-coding RNAs.
  511. Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H., Oligomeric compounds and compositions for use in modulation of small non-coding RNAs.
  512. Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H., Oligomeric compounds and compositions for use in modulation of small non-coding RNAs.
  513. Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H., Oligomeric compounds and compositions for use in modulation of small non-coding RNAs.
  514. Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H.; Marcusson, Eric G., Oligomeric compounds and compositions for use in modulation of small non-coding RNAs.
  515. Esau, Christine; Lollo, Bridget; Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H.; Baker, Brenda F.; Vickers, Timothy A.; Marcusson, Eric G.; Koller, Erich; Swayze, Eric E.; Jain, Ravi; Bhat, Balkrishen; Peralta, Eigen, Oligomeric compounds and compositions for use in modulation of small non-coding RNAs.
  516. Lollo, Bridget; Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H., Oligomeric compounds and compositions for use in modulation of small non-coding RNAs.
  517. Lollo, Bridget; Bennett, C. Frank; Freier, Susan M.; Griffey, Richard H.; Swayze, Eric E.; Jain, Ravi; Bhat, Balkrishen, Oligomeric compounds and compositions for use in modulation of small non-coding RNAs.
  518. Seth, Punit P.; Freier, Susan M.; Monia, Brett P.; Swayze, Eric E., Oligomeric compounds comprising bicyclic nucleosides and uses thereof.
  519. Freier, Susan M.; Swayze, Eric E., Oligomeric compounds comprising bicyclic nucleotides and uses thereof.
  520. Freier, Susan M.; Swayze, Eric E., Oligomeric compounds comprising bicyclic nucleotides and uses thereof.
  521. Thrue, Charlotte Albaek; Hog, Anja Molhart; Kristjansen, Paul E. G., Oligomeric compounds for the modulation of HIF-1A expression.
  522. Thrue, Charlotte Albaek; Hog, Anja Molhart; Kristjansen, Paul E. G., Oligomeric compounds for the modulation of HIF-1A expression.
  523. Thrue, Charlotte Albaek; Hog, Anja Molhart; Kristjansen, Paul E. G., Oligomeric compounds for the modulation of HIF-1alpha expression.
  524. Thrue, Charlotte Albaek; Hog, Anja Molhart; Kristjansen, Paul E. G., Oligomeric compounds for the modulation of HIF-1α expression.
  525. Hanson, Gunnar J.; Rudolph, Alexander Charles; Cai, Bao Zhong; Zhou, Ming; Weller, Dwight D., Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups.
  526. Hanson, Gunnar J.; Rudolph, Alexander Charles; Cai, Bao Zhong; Zhou, Ming; Weller, Dwight D., Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups.
  527. Hanson, Gunnar J.; Rudolph, Charles; Cai, Bao Zhong; Zhou, Ming; Weller, Dwight D., Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups.
  528. Bennett, C. Frank; Freier, Susan M, Oligonucleotide compositions and methods for the modulation of the expression of B7 protein.
  529. Woolf, Tod; Taylor, Margaret, Oligonucleotide compositions with enhanced efficiency.
  530. Woolf, Tod; Taylor, Margaret, Oligonucleotide compositions with enhanced efficiency.
  531. Woolf, Tod; Taylor, Margaret, Oligonucleotide compositions with enhanced efficiency.
  532. Woolf, Tod; Taylor, Margaret, Oligonucleotide compositions with enhanced efficiency.
  533. Wright, Jim A.; Young, Aiping H.; Lee, Yoon S., Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth.
  534. Dale, Roderic M. K.; Arrow, Amy; Thompson, Terry, Oligonucleotide-containing pharmacological compositions and their use.
  535. Eugen Uhlmann DE; Beate Greiner DE; Eberhard Unger DE; Gislinde Gothe DE; Marc Schwerdel DE, Oligonucleotides for the inhibition of human eg5 expression.
  536. Jockers, Ralf; Couturier, Cyril; Uhlmann, Eugen, Oligonucleotides which inhibit expression of the OB-RGRP protein.
  537. Dale, Roderic M.K.; Arrow, Amy; Thompson, Teresa, Oligonucleotide—containing pharmacological compositions and their use.
  538. Crooke, Stanley T., Oligoribonucleotides and ribonucleases for cleaving RNA.
  539. Stein, Cy, Phosphorothioate antisense heparanase oligonucleotides.
  540. Bhat, Balkrishen; Swayze, Eric E.; Prakash, Thazha P.; Allerson, Charles; Dande, Prasad; Griffey, Richard H., Positionally modified siRNA constructs.
  541. Westergaard, Majken; Thrue, Charlotte A.; Rasmussen, Frank W.; Hansen, Henrik F., Potent LNA oligonucleotides for the inhibition of HIF-1A expression.
  542. Westergaard, Majken; Thrue, Charlotte Albaek; Rasmussen, Frank Winther; Hansen, Henrik Frydenlund, Potent LNA oligonucleotides for the inhibition of HIF-1A expression.
  543. Westergaard, Majken; Thrue, Charlotte Albaek; Rasmussen, Frank; Hansen, Henrik Frydenlund, Potent LNA oligonucleotides for the inhibition of HIF-1A expression.
  544. Westergaard, Majken; Thrue, Charlotte Albaek; Rasmussen, Frank Winther; Hansen, Henrik Frydenlund, Potent LNA oligonucleotides for the inhibition of HIF-1a expression.
  545. Webb, Carol; Kincade, Paul, Production of pluripotent cells through inhibition of bright/ARID3a function.
  546. Weinbach, Susan; Tillman, Lloyd G.; Geary, Richard S.; Hardee, Gregory E., Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption.
  547. Tuschl, Thomas; Elbashir, Sayda Mahgoub; Lendeckel, Winfried, RNA interference mediating small RNA molecules.
  548. Tuschl, Thomas; Elbashir, Sayda Mahgoub; Lendeckel, Winfried, RNA interference mediating small RNA molecules.
  549. Tuschl, Thomas; Elbashir, Sayda Mahgoub; Lendeckel, Winfried, RNA interference mediating small RNA molecules.
  550. Tuschl, Thomas; Elbashir, Sayda Mahgoub; Lendeckel, Winfried, RNA interference mediating small RNA molecules.
  551. Tuschl, Thomas; Elbashir, Sayda Mahgoub; Lendeckel, Winfried, RNA interference mediating small RNA molecules.
  552. Tuschl, Thomas; Elbashir, Sayda Mahgoub; Lendeckel, Winfried, RNA interference mediating small RNA molecules.
  553. Tuschl, Thomas; Elbashir, Sayda Mahgoub; Lendeckel, Winfried, RNA interference mediating small RNA molecules.
  554. Tuschl, Thomas; Elbashir, Sayda Mahgoub; Lendeckel, Winfried, RNA interference mediating small RNA molecules.
  555. Tuschl, Thomas; Elbashir, Sayda Mahgoub; Lendeckel, Winfried, RNA interference mediating small RNA molecules.
  556. Tuschl, Thomas; Elbashir, Sayda Mahgoub; Lendeckel, Winfried, RNA interference mediating small RNA molecules.
  557. Tuschl, Thomas; Elbashir, Sayda Mahgoub; Lendeckel, Winfried, RNA interference mediating small RNA molecules.
  558. Tuschl, Thomas; Elbashir, Sayda Mahgoub; Lendeckel, Winfried, RNA interference mediating small RNA molecules.
  559. Baulcombe, David Charles; Hamilton, Andrew John, RNA molecules and vectors for gene silencing.
  560. Baulcombe, David Charles; Hamilton, Andrew John, RNA molecules and vectors for gene silencing.
  561. Tuschl, Thomas; Sharp, Phillip A.; Zamore, Phillip D.; Bartel, David P., RNA sequence-specific mediators of RNA interference.
  562. Tuschl, Thomas; Zamore, Phillip D.; Sharp, Phillip A.; Bartel, David P., RNA sequence-specific mediators of RNA interference.
  563. Tuschl, Thomas; Zamore, Phillip D.; Sharp, Phillip A.; Bartel, David P., RNA sequence-specific mediators of RNA interference.
  564. Tuschl, Thomas; Zamore, Phillip D.; Sharp, Phillip A.; Bartel, David P., RNA sequence-specific mediators of RNA interference.
  565. Tuschl, Thomas; Zamore, Phillip D.; Sharp, Phillip A.; Bartel, David P., RNA sequence-specific mediators of RNA interference.
  566. Tuschl, Thomas; Zamore, Phillip D.; Sharp, Phillip A.; Bartel, David P., RNA sequence-specific mediators of RNA interference.
  567. Tuschl, Thomas; Zamore, Phillip D.; Sharp, Phillip A.; Bartel, David P., RNA sequence-specific mediators of RNA interference.
  568. Tuschl, Thomas; Zamore, Phillip D.; Sharp, Phillip A.; Bartel, David P., RNA sequence-specific mediators of RNA interference.
  569. Tuschl, Thomas; Zamore, Phillip D.; Sharp, Phillip A.; Bartel, David P., RNA sequence-specific mediators of RNA interference.
  570. Tuschl, Thomas; Zamore, Phillip D.; Sharp, Phillip A.; Bartel, David P., RNA sequence-specific mediators of RNA interference.
  571. Soutschek, Juergen; Tan, Pamela; Horton, Jay D.; Brown, Michael S.; Goldstein, Joseph L.; Moon, Young-Ah, RNAi modulation of SCAP and therapeutic uses thereof.
  572. Soutschek, Juergen; Tan, Pamela; Horton, Jay D.; Brown, Michael S.; Goldstein, Joseph L.; Moon, Young-Ah, RNAi modulation of SCAP and therapeutic uses thereof.
  573. Kufe, Donald W., Regulation of cell growth by MUC1.
  574. Makino,Yuichi; Poellinger,Lorenz, Regulation of hypoxia-inducible gene expression with antisense Inhibitory PAS domain protein.
  575. Crooke, Rosanne M.; Graham, Mark J.; Mah, Steven, SNPs of apolipoprotein B and modulation of their expression.
  576. Seth, Punit P.; Oestergaard, Michael; Swayze, Eric E., Selective antisense compounds and uses thereof.
  577. Corey, David R.; Hu, Jiaxin; Matsui, Masayuki, Selective inhibition of polyglutamine protein expression.
  578. Corey, David R.; Hu, Jiaxin; Matsui, Masayuki, Selective inhibition of polyglutamine protein expression.
  579. Bennett, C. Frank; Freier, Susan M.; Greenlee, Sarah; Swayze, Eric E., Selective reduction of allelic variants.
  580. Bennett, C. Frank; Hayden, Michael; Freier, Susan M.; Greenlee, Sarah; Carroll, Jeffrey; Warby, Simon; Swayze, Eric E., Selective reduction of allelic variants.
  581. Baulcombe, David Charles; Hamilton, Andrew John, Short RNA producing gene silencing in cells.
  582. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Short antisense compounds with gapmer configuration.
  583. Gorenstein, David G.; Luxon, Bruce A.; Leary, James; Yang, Xianbin, Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting AP-1 transcription factors.
  584. Graham, Michael Wayne; Rice, Robert Norman, Synthetic genes and genetic constructs.
  585. Graham, Michael Wayne; Rice, Robert Norman, Synthetic genes and genetic constructs.
  586. Graham, Michael Wayne; Rice, Robert Norman, Synthetic genes and genetic constructs.
  587. Graham, Michael Wayne; Rice, Robert Norman, Synthetic genes and genetic constructs.
  588. Graham, Michael Wayne; Rice, Robert Norman, Synthetic genes and genetic constructs.
  589. Graham, Michael Wayne; Rice, Robert Norman, Synthetic genes and genetic constructs comprising same I.
  590. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen, TRPM-2 antisense therapy.
  591. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen, TRPM-2 antisense therapy.
  592. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen, TRPM-2 antisense therapy.
  593. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen, TRPM-2 antisense therapy.
  594. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen, TRPM-2 antisense therapy.
  595. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen, TRPM-2 antisense therapy.
  596. Gleave,Martin; Rennie,Paul S.; Miyake,Hideaki; Nelson,Colleen, TRPM-2 antisense therapy.
  597. Kmiec, Eric B.; Gamper, Howard B.; Rice, Michael C., Targeted chromosomal genomic alterations with modified single stranded oligonucleotides.
  598. Kmiec,Eric B; Gamper,Howard B; Rice,Michael C, Targeted chromosomal genomic alterations with modified single stranded oligonucleotides.
  599. Kmiec,Eric B; Gamper,Howard B; Rice,Michael C, Targeted chromosomal genomic alterations with modified single stranded oligonucleotides.
  600. Lu, Patrick Y.; Xie, Frank Y.; Woodle, Martin C.; Liu, Yijia; Tang, Quinn Q.; Xu, Jun, Targets for tumor growth inhibition.
  601. Bartelmez, Stephen H.; Iversen, Patrick L., Transforming growth factor beta (TGF-β) blocking agent-treated stem cell composition and method.
  602. Heaney,Anthony P.; Melmed,Shlomo, Transgenic cells transfected with pituitary tumor transforming gene (PTTG) ) expression vectors and uses therefor.
  603. Demopulos, Gregory A.; Gaitanaris, George A.; Ciccocioppo, Roberto, Treatment of addiction and impulse-control disorders using PDE7 inhibitors.
  604. Gleave, Martin, Treatment of cancer by inhibition of IGFBP's and clusterin.
  605. Gleave, Martin E., Treatment of cancer by inhibition of IGFBPs and clusterin.
  606. Gleave, Martin E., Treatment of cancer by inhibition of IGFBPs and clusterin.
  607. Gleave, Martin E., Treatment of cancer by inhibition of IGFBPs and clusterin.
  608. Gleave, Martin E., Treatment of cancer by inhibition of IGFBPs and clusterin.
  609. Gleave,Martin; Jansen,Burkhard, Treatment of melanoma by reduction in clusterin levels.
  610. Rodriguez-Lafrasse, Claire; Hadchity, Elie, Treatment of squamous cell carcinoma with HSP27 antisense oligonucleotides and radiotherapy.
  611. Georges,Elias; Serfass,Lucile; Bonneau,Anne Marie; Dallaire,Fr��d��ric, Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease.
  612. Georges, Elias; Serfass, Lucile; Bonneau, Anne Marie; Dallaire, Frédéric, Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease.
  613. Georges, Elias; Serfass, Lucile; Bonneau, Anne-Marie; Dallaire, Frédéric, Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease.
  614. Iversen, Patrick L., dsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups.
  615. McSwiggen,James A., siRNA treatment of diseases or conditions related to levels of IKK-gamma.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로